Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.8, Iss.4, 2004-04, pp. : 440-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

By Katsiki Niki Georgiadou Eleni Hatzitolios Apostolos I.

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1417-1431

Adis International

Access to resources Recommend Favorite

Treatment of polycystic ovary syndrome with insulin-lowering agents

By Wang Ping Streicher Patricia Glueck Charles J

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1177-1189

Informa Healthcare

Access to resources Recommend Favorite

Insulin-sensitisers in the treatment of polycystic ovary syndrome

By Teede Helena J Meyer C Norman RJ

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2419-2427

Informa Healthcare

Access to resources Recommend Favorite

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome

By Pasquali Renato Gambineri Alessandra

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1205-1226

Informa Healthcare

Access to resources Recommend Favorite

Insulin Resistance and Polycystic Ovary Syndrome

Current Pharmaceutical Design, Vol. 22, Iss. 36, 2016-11 ,pp. : 5526-5534

Bentham Science Publishers

Access to resources Recommend Favorite